NO20014757L - C(7)-karbamoyloksysubstituerte taxaner som antitumormidler - Google Patents
C(7)-karbamoyloksysubstituerte taxaner som antitumormidlerInfo
- Publication number
- NO20014757L NO20014757L NO20014757A NO20014757A NO20014757L NO 20014757 L NO20014757 L NO 20014757L NO 20014757 A NO20014757 A NO 20014757A NO 20014757 A NO20014757 A NO 20014757A NO 20014757 L NO20014757 L NO 20014757L
- Authority
- NO
- Norway
- Prior art keywords
- carbamoyloxy
- antitumor agents
- substituted taxanes
- taxanes
- substituted
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D305/00—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
- C07D305/14—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Epoxy Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US17967000P | 2000-02-02 | 2000-02-02 | |
| PCT/US2001/003592 WO2001057028A1 (en) | 2000-02-02 | 2001-02-02 | C7 carbamoyloxy substituted taxanes as antitumor agents |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20014757D0 NO20014757D0 (no) | 2001-10-01 |
| NO20014757L true NO20014757L (no) | 2001-11-29 |
Family
ID=22657498
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20014757A NO20014757L (no) | 2000-02-02 | 2001-10-01 | C(7)-karbamoyloksysubstituerte taxaner som antitumormidler |
Country Status (23)
| Country | Link |
|---|---|
| US (3) | US6359154B2 (no) |
| EP (1) | EP1165549B1 (no) |
| JP (1) | JP2003522168A (no) |
| KR (1) | KR20020002417A (no) |
| CN (1) | CN1362956A (no) |
| AT (1) | ATE392422T1 (no) |
| AU (1) | AU778991B2 (no) |
| BR (1) | BR0104355A (no) |
| CA (1) | CA2368510A1 (no) |
| CZ (1) | CZ20013521A3 (no) |
| DE (1) | DE60133600T2 (no) |
| DK (1) | DK1165549T3 (no) |
| ES (1) | ES2305056T3 (no) |
| HK (1) | HK1047937A1 (no) |
| HU (1) | HUP0200752A3 (no) |
| IL (1) | IL145643A0 (no) |
| MX (1) | MXPA01009923A (no) |
| NO (1) | NO20014757L (no) |
| NZ (1) | NZ514410A (no) |
| PL (1) | PL350024A1 (no) |
| PT (1) | PT1165549E (no) |
| WO (1) | WO2001057028A1 (no) |
| ZA (1) | ZA200108056B (no) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL350075A1 (en) * | 2000-02-02 | 2002-11-04 | Univ Florida State Res Found | Taxane formulations having improved solubility |
| CZ20013521A3 (cs) * | 2000-02-02 | 2002-03-13 | Florida State University Research Foundation, Inc. | C7 karbamoyloxy substituované taxany jako protinádorové látky |
| US7390898B2 (en) | 2002-08-02 | 2008-06-24 | Immunogen Inc. | Cytotoxic agents containing novel potent taxanes and their therapeutic use |
| CA2494074A1 (en) * | 2002-08-02 | 2004-02-12 | Immunogen, Inc. | Cytotoxic agents containing novel potent taxanes and their therapeutic use |
| CN110227164B (zh) * | 2018-03-06 | 2021-11-23 | 江苏吉贝尔药业股份有限公司 | 含酮羰基的疏水性抗肿瘤药物及其缀合物、含有缀合物的纳米制剂及其制备方法及应用 |
Family Cites Families (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4960790A (en) | 1989-03-09 | 1990-10-02 | University Of Kansas | Derivatives of taxol, pharmaceutical compositions thereof and methods for the preparation thereof |
| US5175315A (en) | 1989-05-31 | 1992-12-29 | Florida State University | Method for preparation of taxol using β-lactam |
| FR2679230B1 (fr) * | 1991-07-16 | 1993-11-19 | Rhone Poulenc Rorer Sa | Nouveaux derives d'analogues du taxol, leur preparation et les compositions qui les contiennent. |
| US5283253A (en) | 1991-09-23 | 1994-02-01 | Florida State University | Furyl or thienyl carbonyl substituted taxanes and pharmaceutical compositions containing them |
| US5721268A (en) | 1991-09-23 | 1998-02-24 | Florida State University | C7 taxane derivatives and pharmaceutical compositions containing them |
| US5227400A (en) | 1991-09-23 | 1993-07-13 | Florida State University | Furyl and thienyl substituted taxanes and pharmaceutical compositions containing them |
| US5350866A (en) | 1991-09-23 | 1994-09-27 | Bristol-Myers Squibb Company | 10-desacetoxytaxol derivatives |
| US5243045A (en) | 1991-09-23 | 1993-09-07 | Florida State University | Certain alkoxy substituted taxanes and pharmaceutical compositions containing them |
| US5714513A (en) | 1991-09-23 | 1998-02-03 | Florida State University | C10 taxane derivatives and pharmaceutical compositions |
| US5430160A (en) | 1991-09-23 | 1995-07-04 | Florida State University | Preparation of substituted isoserine esters using β-lactams and metal or ammonium alkoxides |
| DK0552041T3 (da) | 1992-01-15 | 2000-10-09 | Squibb & Sons Inc | Enzymatiske fremgangsmåder til spaltning af enantiomerblandinger af forbindelser, der er nyttige som mellemprodukter ved fr |
| US5272171A (en) | 1992-02-13 | 1993-12-21 | Bristol-Myers Squibb Company | Phosphonooxy and carbonate derivatives of taxol |
| US5614549A (en) * | 1992-08-21 | 1997-03-25 | Enzon, Inc. | High molecular weight polymer-based prodrugs |
| CA2109861C (en) | 1992-12-04 | 1999-03-16 | Shu-Hui Chen | 6,7-modified paclitaxels |
| NZ262030A (en) * | 1993-02-05 | 1997-10-24 | Bryn Mawr College | Process for preparing a taxol intermediate |
| IL109926A (en) | 1993-06-15 | 2000-02-29 | Bristol Myers Squibb Co | Methods for the preparation of taxanes and microorganisms and enzymes utilized therein |
| TW397866B (en) | 1993-07-14 | 2000-07-11 | Bristol Myers Squibb Co | Enzymatic processes for the resolution of enantiomeric mixtures of compounds useful as intermediates in the preparation of taxanes |
| US6100411A (en) | 1994-10-28 | 2000-08-08 | The Research Foundation Of State University Of New York | Taxoid anti-tumor agents and pharmaceutical compositions thereof |
| AU4133096A (en) | 1994-10-28 | 1996-05-23 | Research Foundation Of The State University Of New York, The | Taxoid derivatives, their preparation and their use as antitumor agents |
| US5780653A (en) | 1995-06-07 | 1998-07-14 | Vivorx Pharmaceuticals, Inc. | Nitrophenyl, 10-deacetylated substituted taxol derivatives as dual functional cytotoxic/radiosensitizers |
| CA2231837A1 (en) | 1995-09-13 | 1997-03-20 | Florida State University | Radiosensitizing taxanes and their pharmaceutical preparations |
| CA2253513A1 (en) | 1996-05-06 | 1997-11-13 | Florida State University | 1-deoxy baccatin iii, 1-deoxy taxol and 1-deoxy taxol analogs and method for the preparation thereof |
| US5811452A (en) | 1997-01-08 | 1998-09-22 | The Research Foundation Of State University Of New York | Taxoid reversal agents for drug-resistance in cancer chemotherapy and pharmaceutical compositions thereof |
| US5912264A (en) | 1997-03-03 | 1999-06-15 | Bristol-Myers Squibb Company | 6-halo-or nitrate-substituted paclitaxels |
| US7288665B1 (en) | 1997-08-18 | 2007-10-30 | Florida State University | Process for selective derivatization of taxanes |
| CZ20013521A3 (cs) * | 2000-02-02 | 2002-03-13 | Florida State University Research Foundation, Inc. | C7 karbamoyloxy substituované taxany jako protinádorové látky |
-
2001
- 2001-02-02 CZ CZ20013521A patent/CZ20013521A3/cs unknown
- 2001-02-02 CA CA002368510A patent/CA2368510A1/en not_active Withdrawn
- 2001-02-02 AT AT01905421T patent/ATE392422T1/de not_active IP Right Cessation
- 2001-02-02 MX MXPA01009923A patent/MXPA01009923A/es active IP Right Grant
- 2001-02-02 IL IL14564301A patent/IL145643A0/xx unknown
- 2001-02-02 EP EP01905421A patent/EP1165549B1/en not_active Expired - Lifetime
- 2001-02-02 PT PT01905421T patent/PT1165549E/pt unknown
- 2001-02-02 HU HU0200752A patent/HUP0200752A3/hu unknown
- 2001-02-02 US US09/776,494 patent/US6359154B2/en not_active Expired - Fee Related
- 2001-02-02 ES ES01905421T patent/ES2305056T3/es not_active Expired - Lifetime
- 2001-02-02 WO PCT/US2001/003592 patent/WO2001057028A1/en active Application Filing
- 2001-02-02 PL PL01350024A patent/PL350024A1/xx not_active Application Discontinuation
- 2001-02-02 CN CN01800316A patent/CN1362956A/zh active Pending
- 2001-02-02 JP JP2001557860A patent/JP2003522168A/ja not_active Withdrawn
- 2001-02-02 AU AU33302/01A patent/AU778991B2/en not_active Ceased
- 2001-02-02 BR BR0104355-2A patent/BR0104355A/pt not_active IP Right Cessation
- 2001-02-02 DE DE60133600T patent/DE60133600T2/de not_active Expired - Fee Related
- 2001-02-02 KR KR1020017012622A patent/KR20020002417A/ko active IP Right Grant
- 2001-02-02 NZ NZ514410A patent/NZ514410A/en unknown
- 2001-02-02 DK DK01905421T patent/DK1165549T3/da active
- 2001-10-01 ZA ZA200108056A patent/ZA200108056B/en unknown
- 2001-10-01 NO NO20014757A patent/NO20014757L/no not_active Application Discontinuation
-
2002
- 2002-02-06 US US10/071,924 patent/US6750245B2/en not_active Expired - Fee Related
-
2003
- 2003-01-07 HK HK03100171.8A patent/HK1047937A1/zh unknown
-
2004
- 2004-06-14 US US10/867,275 patent/US20050020635A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| DE60133600T2 (de) | 2009-06-10 |
| PL350024A1 (en) | 2002-10-21 |
| US20010051640A1 (en) | 2001-12-13 |
| EP1165549A1 (en) | 2002-01-02 |
| AU3330201A (en) | 2001-08-14 |
| CN1362956A (zh) | 2002-08-07 |
| US20050020635A1 (en) | 2005-01-27 |
| HUP0200752A3 (en) | 2005-02-28 |
| BR0104355A (pt) | 2002-01-02 |
| US20030060638A1 (en) | 2003-03-27 |
| EP1165549B1 (en) | 2008-04-16 |
| AU778991B2 (en) | 2004-12-23 |
| HUP0200752A2 (en) | 2002-10-28 |
| CZ20013521A3 (cs) | 2002-03-13 |
| JP2003522168A (ja) | 2003-07-22 |
| WO2001057028A1 (en) | 2001-08-09 |
| DE60133600D1 (de) | 2008-05-29 |
| ES2305056T3 (es) | 2008-11-01 |
| ATE392422T1 (de) | 2008-05-15 |
| MXPA01009923A (es) | 2003-08-01 |
| KR20020002417A (ko) | 2002-01-09 |
| DK1165549T3 (da) | 2008-08-11 |
| ZA200108056B (en) | 2003-12-01 |
| CA2368510A1 (en) | 2001-08-09 |
| HK1047937A1 (zh) | 2003-03-14 |
| PT1165549E (pt) | 2008-06-20 |
| NZ514410A (en) | 2005-01-28 |
| IL145643A0 (en) | 2002-06-30 |
| US6750245B2 (en) | 2004-06-15 |
| US6359154B2 (en) | 2002-03-19 |
| NO20014757D0 (no) | 2001-10-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BG105967A (en) | C(7) ester substituted taxanes and their use as antitumor agents | |
| NO20014756D0 (no) | C(10)-heterosubstituerte acetattaksaner som antitmormidler | |
| NO20014758L (no) | C(7)-heterosubstituerte acetattaxaner som antitumormidler | |
| BG105964A (en) | C(10) carbonate substituted taxanes and their use as antitumor agents | |
| NO20014757D0 (no) | C(7)-karbamoyloksysubstituerte taksaner som antitumormidler | |
| NO20014760D0 (no) | C(10)-karbamoyloksysubstituerte taksaner som antitumormidler | |
| NO20014754D0 (no) | C(10)-estersubstituerte taksaner som antitumormidler | |
| BG105966A (en) | C7 carbonate substituted taxanes and their application as antitumor agents | |
| ATE282611T1 (de) | Stolonoxide | |
| SG125888A1 (en) | C10 carbonate substituted taxanes |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |